What type of study is this?

Evaluation of Cardiovascular, Maternal, and Neonatal Outcomes with Three Different Dexmedetomidine Doses in Elective Caesarean Deliveries

View Full Paper

Ask AI

Bookmark

Authors

Comparative analysis of dexmedetomidine doses on maternal and neonatal outcomes, revealing key hemodynamic effects.

Group C (DEX 0.6) showed the best uterine relaxation and sedation levels, improving maternal outcomes significantly.
Lowest visual analog scale scores for uterine relaxation and reduced supplementary oxytocin were observed in Group C.
Pre-operative dexmedetomidine at higher doses of 0.4 or 0.6 mcg/kg/hour effectively mitigated hemodynamic responses.
Neonatal health was consistent across groups, indicating no adverse effects from the dexmedetomidine administration.

Verma et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark